Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 7, Issue 12 (2018)

A review on insomnia: The sleep disorder

Author(s):
CH B Praveena Devi, Shahesta Samreen, N Kusuma Kumari and JVC Sharma
Abstract:
Insomnia is difficulty falling asleep or staying asleep, even when a person has the chance to do so. People with insomnia can feel dissatisfied with their sleep and usually experience one or more of the symptoms like fatigue, low energy, difficulty concentrating, mood disturbances, and decreased performance in work. Insomnia may be characterized based on its duration. Acute insomnia is brief and often happens because of life circumstances. Many people might have experienced this type of passing sleep disruption, and it tends to resolve without any treatment. Chronic insomnia is disrupted sleep that occurs at least three nights per week and lasts at least three months. Chronic insomnia disorders can have many causes. Insomnia results due to an imbalance between sleep inducing neurotransmitters. There are few methods and indexes reported to study about the sleep disorders in insomnia patients like Insomnia Severity Index, Pittsburgh Sleep Quality Index. The treatment includes many drugs like Anti-Depressants, Benzodiazepines and also intake of Melatonin rich milk was also found to be effective.
Pages: 227-230  |  347 Views  22 Downloads
How to cite this article:
CH B Praveena Devi, Shahesta Samreen, N Kusuma Kumari, JVC Sharma. A review on insomnia: The sleep disorder. Pharma Innovation 2018;7(12):227-230.
The Pharma Innovation Journal